Patents by Inventor Phil Jun KANG

Phil Jun KANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12397020
    Abstract: A method for inducing reprogramming of neural stem cells from urine cells by introducing mRNAs of reprogramming factors Oct4, Sox2, Klf4, and Glis1 is disclosed. A composition for the prevention or treatment of neurological damage diseases with the neural stem cells induced by the method as an active ingredient is disclosed.
    Type: Grant
    Filed: August 28, 2019
    Date of Patent: August 26, 2025
    Assignee: STEMLAB, INC.
    Inventors: Seung Kwon You, Phil Jun Kang, Da Ryeon Son, Won Jun Hong, Won Jin Yun, Jang Bo Lee, Gyu Man Park, In Yong Kim, Jung Hyun Park, Jie Zheng, Wei Wei Gao, Ji Hoon Jang, Eun Kyoung Jun, Byung Sun Yoon
  • Publication number: 20220177851
    Abstract: Disclosed is a method for inducing direct reprogramming of urine cells into renal progenitor cells and a pharmaceutical composition including the renal progenitor cells reprogrammed by the method for preventing or treating renal cell injury disease. The method can make the mass production of customized reprogrammed renal progenitor cells by using urine cells, which are somatic cells easily and repeatedly obtainable without inconvenience and pain and as such, can be applied to incurable disease fields expandable to the renal injury therapy and kidney regeneration fields and to the production of cell therapy products.
    Type: Application
    Filed: April 9, 2020
    Publication date: June 9, 2022
    Inventors: Seung Kwon YOU, In Yong KIM, Wei Wei GAO, Phil Jun KANG, Won-Jin YUN, Gyuman PARK
  • Publication number: 20210260132
    Abstract: A method for inducing reprogramming of neural stem cells from urine cells by introducing mRNAs of reprogramming factors Oct4, Sox2, Klf4, and Glis1 is disclosed. A composition for the prevention or treatment of neurological damage diseases with the neural stem cells induced by the method as an active ingredient is disclosed.
    Type: Application
    Filed: August 28, 2019
    Publication date: August 26, 2021
    Inventors: Seung Kwon YOU, Phil Jun KANG, Da Ryeon SON, Won Jun HONG, Won Jin YUN, Jang Bo LEE, Gyu Man PARK, In Yong KIM, Jung Hyun PARK, Jie ZHENG, Wei Wei GAO, Ji Hoon JANG, Eun Kyoung JUN, Byung Sun YOON